124 related articles for article (PubMed ID: 32234922)
1. An Instrument to Guide Physicians when Estimating the Survival of Elderly Patients With Brain Metastasis from Gynecological Cancer.
Rades D; Nguyen T; Janssen S; Schild SE
Anticancer Res; 2020 Apr; 40(4):2257-2260. PubMed ID: 32234922
[TBL] [Abstract][Full Text] [Related]
2. An Instrument for Estimating the 6-Month Survival Probability After Whole-brain Irradiation Alone for Cerebral Metastases from Gynecological Cancer.
Janssen S; Hansen HC; Schild SE; Rades D
Anticancer Res; 2018 Jun; 38(6):3753-3756. PubMed ID: 29848738
[TBL] [Abstract][Full Text] [Related]
3. A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort.
Janssen S; Hansen HC; Dziggel L; Schild SE; Rades D
Radiol Oncol; 2019 May; 53(2):219-224. PubMed ID: 31103998
[TBL] [Abstract][Full Text] [Related]
4. Remaining Lifespan of Patients Aged ≥65 Years Receiving Whole-brain Irradiation for Metastases from Cancer of Unknown Primary.
Rades D; Nguyen T; Khoa MT; Janssen S; Schild SE
Anticancer Res; 2020 Apr; 40(4):2261-2264. PubMed ID: 32234923
[TBL] [Abstract][Full Text] [Related]
5. Shorter-course whole-brain radiotherapy for brain metastases in elderly patients.
Rades D; Evers JN; Veninga T; Stalpers LJ; Lohynska R; Schild SE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e469-73. PubMed ID: 21477949
[TBL] [Abstract][Full Text] [Related]
6. A Specific Survival Score for Patients Receiving Local Therapy for Single Brain Metastasis from a Gynecological Malignancy.
Rades D; Dziggel L; Schild SE
In Vivo; 2018; 32(4):825-828. PubMed ID: 29936465
[TBL] [Abstract][Full Text] [Related]
7. A New Diagnosis-Specific Survival Score for Patients to be Irradiated for Brain Metastases from Non-small Cell Lung Cancer.
Rades D; Hansen HC; Schild SE; Janssen S
Lung; 2019 Jun; 197(3):321-326. PubMed ID: 30927058
[TBL] [Abstract][Full Text] [Related]
8. Performance Status Is Associated With Survival in Elderly Patients Irradiated for Cerebral Metastases from Prostate Cancer.
Nguyen T; Bartscht T; Schild SE; Rades D
Anticancer Res; 2020 Mar; 40(3):1665-1668. PubMed ID: 32132072
[TBL] [Abstract][Full Text] [Related]
9. A Simple Implement for Assessing the Survival of Elderly Patients With Melanoma Irradiated for Cerebral Metastases.
Nguyen T; Janssen S; Schild SE; Rades D
In Vivo; 2020; 34(3):1361-1364. PubMed ID: 32354931
[TBL] [Abstract][Full Text] [Related]
10. The Results of Whole-brain Radiotherapy for Elderly Patients With Brain Metastases from Urinary Bladder Cancer.
Rades D; Nguyen T; Schild SE
In Vivo; 2020; 34(3):1317-1320. PubMed ID: 32354924
[TBL] [Abstract][Full Text] [Related]
11. A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients.
Evers JN; Schild SE; Segedin B; Nagy V; Khoa MT; Trang NT; Rades D
Anticancer Res; 2014 May; 34(5):2455-8. PubMed ID: 24778060
[TBL] [Abstract][Full Text] [Related]
12. Estimating the Lifespan of Elderly Patients With Cerebral Metastases from Kidney Cancer.
Rades D; Nguyen T; Schild SE
In Vivo; 2020; 34(3):1321-1324. PubMed ID: 32354925
[TBL] [Abstract][Full Text] [Related]
13. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
14. Elderly Patients With Single Brain Metastasis - Overall Survival After Surgery Plus Whole-Brain Irradiation and a Radiation Boost.
Rades D; Nguyen T; Schild SE
In Vivo; 2020; 34(3):1421-1425. PubMed ID: 32354940
[TBL] [Abstract][Full Text] [Related]
15. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
16. Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.
Dziggel L; Gebauer N; Bartscht T; Schild SE; Rades D
Anticancer Res; 2018 Apr; 38(4):2391-2394. PubMed ID: 29599366
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
18. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
19. Predicting Survival After Whole-brain Irradiation for Cerebral Metastases in Patients with Cancer of the Bladder.
Rades D; Dziggel L; Manig L; Janssen S; Khoa MT; Duong VN; Khiem VH; Schild SE
In Vivo; 2018; 32(3):633-636. PubMed ID: 29695570
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
